at MarketWatch.com (Jun 6, 2014)
Cardiovascular Systems (CSII) guides its FQ1 lower, now seeing revenue at $18.7M. The company says a shift in peripheral arterial disease procedures to physician-based labs caused hospital-based procedures and related purchases to decrease. Shares -7.9% AH.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs